Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Multiple Sclerosis l: Introduction

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Measles Seroprevalence Among Healthcare Workers in a Tertiary Hospital in Central Greece, 2017.

Vaccines·2026

Same author

Evaluation of the Effectiveness of a School-Based Smoking Prevention Program Among Young Adolescents in Central Greece: An Analytical, Non-Randomized Interventional Study.

International journal of environmental research and public health·2026

Same author

In Vivo Mapping of Catecholaminergic Loss and Iron Deposition in Huntington's Disease.

Movement disorders : official journal of the Movement Disorder Society·2026

Same author

Loss of serotonergic function in carriers of PRKN mutations: a [<sup>11</sup>C]DASB PET study.

European journal of nuclear medicine and molecular imaging·2026

Same author

Immune alterations in schizophrenia and the effects of a therapeutic antibody: a neuroimaging study.

Brain : a journal of neurology·2025

Same author

An in vivo PET/CT investigation of mitochondrial complex 1, sigma 1, and synaptic vesicle 2 A in patients with amyotrophic lateral sclerosis.

Neurobiology of disease·2025

Same journal

Intense Incidental F-18 DOPA Uptake in Low-grade Prostate Adenocarcinoma: A Potential Diagnostic Pitfall.

Clinical nuclear medicine·2026

Same journal

A Prospective Head-to-Head Comparison of HER2-Targeted and 18F-FDG PET/CT for Detecting Axillary Lymph Node Metastases Among Newly Diagnosed HER2-Positive and HER2-Low Breast Cancer.

Clinical nuclear medicine·2026

Same journal

Epileptogenic Brain Metastasis Early Positive on 18FDG PET/CT Compared to MRI.

Clinical nuclear medicine·2026

Same journal

Dural Manifestation of Langerhans Cell Histiocytosis: Multimodality Imaging Approach.

Clinical nuclear medicine·2026

Same journal

Malignant Perivascular Epithelioid Cell Tumor (PEComa) of Left Adrenal Gland With Extensive Intravenous Tumor Thrombi: 18F-FDG PET/CT Findings.

Clinical nuclear medicine·2026

Same journal

18F-MFBG Uptake From Multiple Focal "Hot Spots" to Superscan in a Pediatric Patient With High-risk Neuroblastoma.

Clinical nuclear medicine·2026

See all related articles

Search research articles

Related Experiment Video

Updated: May 2, 2026

Positron Emission Tomography Imaging for In Vivo Measuring of Myelin Content in the Lysolecithin Rat Model of Multiple Sclerosis

Positron Emission Tomography Imaging for In Vivo Measuring of Myelin Content in the Lysolecithin Rat Model of Multiple Sclerosis

Published on: February 28, 2021

PET in multiple sclerosis.

Flavia Niccolini¹, Paul Su, Marios Politis

¹From the *Division of Brain Sciences, Department of Medicine, Hammersmith Hospital, Imperial College London; and †Neurodegeneration Imaging Group, Department of Clinical Neuroscience, King's College London, London, United Kingdom.

Clinical Nuclear Medicine

|February 25, 2014

Summary

This summary is machine-generated.

Positron Emission Tomography (PET) offers advanced in vivo brain imaging for multiple sclerosis (MS) research, potentially surpassing MRI limitations. Future PET applications may aid MS diagnosis, monitoring, and treatment development.

More Related Videos

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines

Published on: September 21, 2021

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

Related Experiment Videos

Last Updated: May 2, 2026

Positron Emission Tomography Imaging for In Vivo Measuring of Myelin Content in the Lysolecithin Rat Model of Multiple Sclerosis

Positron Emission Tomography Imaging for In Vivo Measuring of Myelin Content in the Lysolecithin Rat Model of Multiple Sclerosis

Published on: February 28, 2021

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines

Published on: September 21, 2021

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

Area of Science:

Neuroscience
Medical Imaging
Radiochemistry

Background:

Positron Emission Tomography (PET) is a functional imaging technique for in vivo brain studies.
Magnetic Resonance Imaging (MRI) is currently primary for monitoring multiple sclerosis (MS) clinical progression.
Recent PET advancements show potential for assessing the MS brain beyond MRI capabilities.

Purpose of the Study:

To explore the evolving role of PET imaging in understanding multiple sclerosis (MS) pathophysiology.
To highlight PET's potential in investigating neuroinflammation, neuronal dysfunction, and myelin dynamics in MS.
To discuss the future clinical applications of PET in MS diagnosis, monitoring, and drug development.

Main Methods:

Review of current and emerging PET imaging techniques for neurological disorders.
Analysis of PET's capacity for in vivo quantification of biological targets in the central nervous system.
Discussion of the integration of PET with existing diagnostic tools like MRI for MS.

Main Results:

PET can provide unique insights into MS pathophysiology, including neuroinflammation and myelin repair, which are challenging for MRI.
Quantitative molecular data from PET may support clinical trials for novel MS therapeutics.
PET imaging offers noninvasive assessment of biological targets crucial for understanding MS.

Conclusions:

PET imaging holds significant promise for advancing the understanding and clinical management of multiple sclerosis (MS).
Overcoming cost and accessibility limitations of PET technology is crucial for its widespread clinical adoption in MS.
PET could become an invaluable tool for accurate MS diagnosis, progression monitoring, and personalized treatment planning.